Dr. Janeway is a pediatric oncologist and senior physician at Dana-Farber/Boston Children's Cancer and Blood Disorders Center. She is the Director of Clinical Genomics at Dana-Farber Cancer Institute and her research is focused on genomics, precision oncology and bone sarcomas. She leads clinical trials in osteosarcoma and Ewing sarcoma both as an independent investigator and as the Chair of the Children's Oncology Group (COG) Bone Tumor Committee.
In this episode we discuss:
- What led her into medicine, pediatric oncology and sarcoma research
- How do we begin to define precision medicine in Osteosarcoma - start with defining subtypes
- Ways that Dr. Janeway is spearheading defining the osteosarcoma subtypes through genomic and clinical data collection
- How patients and advocacy groups are leading the way in research efforts and information on Count Me In Osteosarcoma Project
- Two Phase 3 clinical trials Dr. Janeway is working on and how they will be moving the needle in making progress in Osteosarcoma in a variety of areas (genomics, quality of life, and surgical resection)
music Rosepigg
photo Eric Prouzet
